| Cardiovascular medication type | Moderate-to-vigorous physical activity (min/week) | |||
| <150 (%) | ⩾150* (%) | Total (%) | p Value† | |
| Positive inotropic drugs | 4.8 | 1.6 | 3.8 | <0.001 |
| Diuretics | 46.3 | 40.4 | 44.5 | 0.002 |
| Antiarrhythmic drugs | 1.7 | 1.3 | 1.5 | 0.435 |
| β blockers | 28.0 | 26.9 | 27.7 | 0.527 |
| ACE inhibitors | 26.1 | 25.4 | 25.9 | 0.674 |
| Nitrates, and other antianginal drugs | 3.4 | 1.7 | 2.9 | 0.07 |
| Calcium channel blockers | 22.3 | 16.8 | 20.7 | <0.001 |
| Anticoagulants | 4.5 | 2.2 | 3.9 | 0.001 |
| Antiplatelet agents | 17.9 | 18.1 | 17.9 | 0.912 |
| Lipid-regulating agents | 11.6 | 15.7 | 12.8 | 0.002 |
Respondents had no self-reported diagnosis of coronary heart disease (angina or myocardial infarction) or stroke and were currently receiving cardiovascular medication.
*Meeting the current physical activity recommendations; †p values are based on likelihood ratios and refer to the difference between those who met the physical activity recommendations and those who did not.